Patent · US Active

(S)-N-methylnaltrexone

US8003794B2 · kind B2 · utility

3Cited by

160References

12Claims

0Family size

Assignee

Progenics Pharmaceuticals, Inc. · US

Inventors

Thomas A. Boyd · Austin, US
Howard Wagoner · Monroe, US
Suketu Sanghvi · Kendall Park, US
Christopher Verbicky · Broadalbin, US
Stephen Andruski · Clifton Park, US

Key dates

Filing date	Jul 20, 2009
Grant date	Aug 23, 2011
Priority date	—
Expiry date	Jan 20, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to S-MNTX, methods of producing S-MNTX, pharmaceutical preparations comprising S-MNTX and methods for their use.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.